Apellis Pharmaceuticals Inc (NAS:APLS)
$ 36.8 -1.58 (-4.12%) Market Cap: 4.48 Bil Enterprise Value: 4.79 Bil PE Ratio: 0 PB Ratio: 17.66 GF Score: 37/100

Apellis Pharmaceuticals Inc (APLS) Transcripts

  • 1